Experimental Study on the Effect of Atractylenolide Ⅱ Regulated YAP Signaling Pathway on Joint Function and Splenic Treg/Th17 Expression in Rats Model with Rheumatoid Arthritis
10.3969/j.issn.1671-7414.2025.04.015
- VernacularTitle:白术内酯Ⅱ调节YAP信号通路对类风湿关节炎模型大鼠关节功能和脾脏Treg/Th17表达影响的实验研究
- Author:
Yue WU
1
;
Yao XUE
1
;
Lili CHEN
1
Author Information
1. 东南大学附属中大医院江北院区药剂科,南京 211500
- Publication Type:Journal Article
- Keywords:
atractylenolide Ⅱ;
rheumatoid arthritis;
Yes-associated protein signaling pathway;
regulatory T cell/helper T cell 17
- From:
Journal of Modern Laboratory Medicine
2025;40(4):86-90
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of atractylenolide Ⅱ regulated Yes associated protein(YAP)signaling pathway on joint function and splenic regulatory T cells(Treg)/helper T cell 17(Th17)expression in rheumatoid arthritis(RA)model rats.Methods The RA rat model was constructed,and SD rats were separated into a control group,a model group,a low-dose atractylenolide Ⅱ group(10 mg/kg/d),a high-dose atractylenolide Ⅱ group(50 mg/kg/d),and a high-dose atractylenolideⅡ+YAP activator(PY60)group.On the 1st,7th and 14th day of the dosing period,rats were weighed and the joint swelling rate was evaluated,the arthritis index was scored after administration;HE staining was applied to observe pathological changes;flow cytometry was applied to detect the proportions of Treg and Th17 cells in splenic tissue;Western blot(WB)was applied to detect the expression levels of phosphorylation(p)in metatarsal tissue-mammalian STE20-like protein kinase 1(p-MST1),MST1,phospho-large tumor suppressor gene 1(p-LATS1),LATS1,phospho-Yes associated protein(p-YAP)and YAP proteins.Results Compared with the control group,rats in the model group suffered from damage to the metatarsal cartilage tissue,resulting in weight loss and increased joint swelling rate during the administration period,during the administration period,the body weight was lower and the joint swelling rate was higher,the arthritis index score,Mankin score,proportion of spleen Th17 cells,and the expression level of metatarsal p-YAP/YAP protein were higher,the proportion of Treg cells and the expression levels of p-MST1/MST1 and p-LATS1/LATS1 proteins were lower,and the differences were statistically significant(t=4.953～38.268,all P<0.05).Compared with the model group,the cartilage tissue damage in the low and high dose atractylenolide Ⅱ groups was reduced,during the administration period,the body weight was higher and the joint swelling rate was lower,the arthritis index score,Mankin score,proportion of spleen Th17 cells,and the expression level of metatarsal p-YAP/YAP protein were lower,the proportion of Treg cells and the expression levels of p-MST1/MST1 and p-LATS1/LATS1 proteins were higher,the differences were statistically significant(tlow dose=4.050～17.013,thigh dose=6.379～32.174,all P<0.05).Compared to the high-dose atractylenolide Ⅱ group,the damage to the cartilage tissue of the metatarsal bone in the high-dose atractylenolideⅡ+PY60 group was worsened,during the administration period,the body weight was lower and the joint swelling rate was higher,the arthritis index score,Mankin score,proportion of spleen Th17 cells,and the expression level of metatarsal p-YAP/YAP protein were higher,the proportion of Treg cells and the expression levels of p-MST1/MST1 and p-LATS1/LATS1 proteins were lower,and the differences were statistically significant(t=5.084～27.703,all P<0.05).Conclusion Atractylenolide Ⅱ inhibits the activation of YAP signaling pathway,regulates splenic Treg/Th17 cell balance and ameliorates disease progression in RA rats.
